Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JORGE ARTURO DIAZ CASTRO

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1558517987
CMS profile
749526
Location
HUNTSVILLE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$2,522.52

189 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,522.52 189

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JORGE ARTURO DIAZ CASTRO

NPI 1558517987 · CMS profile ID 749526

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

HUNTSVILLE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1558517987?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JORGE ARTURO DIAZ CASTRO, NPI 1558517987, CMS profile ID 749526. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1558517987?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JORGE ARTURO DIAZ CASTRO, NPI 1558517987, CMS profile ID 749526. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1558517987?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JORGE ARTURO DIAZ CASTRO, NPI 1558517987, CMS profile ID 749526, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1558517987?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

189 matching records · $2,522.52 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 189 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 189.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $8.4107/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673758475 CMS
Lilly USA, LLC $13.6807/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657919785 CMS
E.R. Squibb & Sons, L.L.C. $13.4607/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651362143 CMS
PFIZER INC. $12.1607/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672275169 CMS
Novartis Pharmaceuticals Corporation $6.4206/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658997057 CMS
Novartis Pharmaceuticals Corporation $9.4906/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658997069 CMS
Regeneron Healthcare Solutions, Inc. $16.6206/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673369927 CMS
Astellas Pharma US Inc $13.8606/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655539453 CMS
E.R. Squibb & Sons, L.L.C. $13.1306/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651362131 CMS
EISAI INC. $22.4406/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697007361 CMS
Lilly USA, LLC $22.4206/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657899117 CMS
Janssen Biotech, Inc. $20.2005/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658401757 CMS
Bayer HealthCare Pharmaceuticals Inc. $11.1805/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 628469491 CMS
Lilly USA, LLC $8.2005/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657902715 CMS
AstraZeneca Pharmaceuticals LP $16.6205/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685218469 CMS
Pharmacyclics LLC, An AbbVie Company $11.4905/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 665707975 CMS
E.R. Squibb & Sons, L.L.C. $9.5705/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651362121 CMS
Merck Sharp & Dohme Corporation $11.3705/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695472069 CMS
EISAI INC. $19.5005/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697008563 CMS
Seattle Genetics, Inc. $15.5005/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 678801543 CMS
Amgen Inc. $14.6405/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662557661 CMS
PFIZER INC. $11.2705/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672007537 CMS
EISAI INC. $22.4305/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697008729 CMS
Partner Therapeutics, Inc. $14.1305/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706330615 CMS
EISAI INC. $1.8705/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697008887 CMS
AbbVie, Inc. $15.8205/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647998561 CMS
Merck Sharp & Dohme Corporation $15.3605/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695443051 CMS
EISAI INC. $11.4205/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697002755 CMS
Merck Sharp & Dohme Corporation $13.3605/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695447873 CMS
E.R. Squibb & Sons, L.L.C. $10.6904/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651362107 CMS
E.R. Squibb & Sons, L.L.C. $10.1304/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651362117 CMS
Genentech USA, Inc. $11.3304/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681191665 CMS
Ipsen Biopharmaceuticals, Inc $13.9104/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 640630775 CMS
PFIZER INC. $11.9404/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672694861 CMS
Genentech USA, Inc. $13.0704/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681289171 CMS
AstraZeneca Pharmaceuticals LP $18.2804/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685994185 CMS
Helsinn Therapeutics (U.S.), Inc. $13.5704/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655944957 CMS
Pharmacyclics LLC, An AbbVie Company $13.3404/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 665704899 CMS
Dendreon Pharmaceuticals LLC $13.6604/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703759899 CMS
E.R. Squibb & Sons, L.L.C. $11.2504/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651362119 CMS
Astellas Pharma US Inc $19.0804/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655539451 CMS
EISAI INC. $14.7304/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697005361 CMS
Merck Sharp & Dohme Corporation $14.8204/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695419449 CMS
E.R. Squibb & Sons, L.L.C. $13.0204/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651362105 CMS
Lilly USA, LLC $10.7504/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657906147 CMS
AstraZeneca Pharmaceuticals LP $15.8204/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685630979 CMS
Array BioPharma Inc. $22.8204/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700973849 CMS
Amgen Inc. $15.6404/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662557697 CMS
Novartis Pharmaceuticals Corporation $14.4403/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658997081 CMS
Lilly USA, LLC $13.4503/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657923189 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,522.52 189
PY2020 $1,289.47 60
PY2021 $1,078.73 36
PY2022 $1,639.38 89
PY2023 $1,759.35 79
PY2024 $2,670.29 101
PY2025 $2,950.31 115

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $8,780.35 9
PY2024 Principal investigator $20,600.00 9
PY2023 Principal investigator $7,061.00 2
PY2022 Principal investigator $19,195.75 11
PY2021 Principal investigator $5,765.36 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,500.00 10/30/2025 Non-covered Recipient Entity
ONCOLOGY SPECIALTIES PC
CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY No dispute reported 06/30/2026 1184255697
Principal investigator 1 Incyte Corporation $175.00 08/04/2025 Non-covered Recipient Entity
Oncology Specialties, P.C.
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL (realMIND) No dispute reported 06/30/2026 1240571338
Principal investigator 1 Eli Lilly and Company $895.06 05/27/2025 Non-covered Recipient Entity
ONCOLOGY SPECIALTIES PC
A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF OLOMORASIB IN COMBINATION WITH STANDARD OF CARE IMMUNOTHERAPY IN PARTICIPANTS WITH RESECTED OR UNRESECTABLE KRAS G12C-MUTANT, NON-SMALL CELL LUNG CANCER - SUNRAY-02 No dispute reported 06/30/2026 1187888474
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $3,724.29 05/08/2025 Non-covered Recipient Entity
ONCOLOGY SPECIALTIES PC
CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY No dispute reported 06/30/2026 1184193683
Principal investigator 1 Incyte Corporation $601.00 04/23/2025 Non-covered Recipient Entity
ONCOLOGY-SPECIALTIES PC
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL (realMIND) No dispute reported 06/30/2026 1240571361
Principal investigator 1 Incyte Corporation $1,350.00 04/23/2025 Non-covered Recipient Entity
ONCOLOGY-SPECIALTIES PC
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL (realMIND) No dispute reported 06/30/2026 1240571368
Principal investigator 1 Incyte Corporation $185.00 03/14/2025 Non-covered Recipient Entity
ONCOLOGY-SPECIALTIES PC
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL (realMIND) No dispute reported 06/30/2026 1240571344
Principal investigator 1 Incyte Corporation $175.00 03/14/2025 Non-covered Recipient Entity
ONCOLOGY-SPECIALTIES PC
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL (realMIND) No dispute reported 06/30/2026 1240571350
Principal investigator 1 Incyte Corporation $175.00 03/14/2025 Non-covered Recipient Entity
ONCOLOGY-SPECIALTIES PC
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL (realMIND) No dispute reported 06/30/2026 1240571356